TORONTO, ONTARIO--(Marketwired - April 26, 2013) - BIOSENTA INC. (CNSX:ZRO) (the "Company") announces that it has accepted the resignation of Mr. Allan Gibbins as a director of the Company effective April 26, 2013. Mr. Gibbins will not be standing for re-election as a director at the Company's upcoming annual meeting of shareholders to be held May 29, 2013. The Company wishes to extend its appreciation to Mr. Gibbins for his services.
About Biosenta Inc.
Biosenta Inc.'s line of retail anti-microbial products will effectively kill mould, bacteria and fungi on contact and prevent re-growth. These products address the demand created by the mounting health and environmental concerns. Mould can affect the immune system, nervous system, liver, kidneys, blood and cause brain damage.
Biosenta will also manufacture and distribute an anti-microbial filler. Calcium Carbonate is one of the most common fillers used industrially. It is susceptible like other fillers that hold moisture to attracting mould. Annual global revenue in the calcium carbonate filler industry approximates 140 billion dollars. Biosenta will produce anti-microbial filler that performs 'filling' and 'bulking' functions like calcium carbonate. Biosenta's filler product will not attract moisture and consequently mould infestation. Biosenta's filler with its anti-microbial high ph core in individual particles will enhance commercial product life and eradicate a broad spectrum of known bacteria, fungi, algae and other micro-organisms by suppression of their reproduction.
On behalf of the Board of Directors of Biosenta Inc.
Bruce Lewis, Chairman
The CNSX has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved of the contents of this press release. Neither the CNSX nor its Regulation Services Provider (as such term is defined in the policies of the CNSX) accepts responsibility for the adequacy or accuracy of this release.